REGISTERED
on 15 Oct 2024
Last Applicant/ Owned by
Rue de l'Institut 89
Rixensart
B-1330
Serial Number
98271187 filed on 15th Nov 2023
Registration Number
7535227 registered on 15th Oct 2024
Correspondent Address
Christopher M. Hanes
Filing Basis
No Filing Basis
Disclaimer
NO DATA
AUXVALI
Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepat Read More
Classification Information
Class [005]
Pharmaceutical Products
Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders;
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 98271187
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 84269798
44D Filed
Yes
44D Current
Yes
44E filed
Yes
44E Current
Yes
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 15th Oct 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 15th Oct 2024 | REGISTERED-PRINCIPAL REGISTER |
| 30th Jul 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 30th Jul 2024 | PUBLISHED FOR OPPOSITION |
| 10th Jul 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 21st Jun 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 20th Jun 2024 | ASSIGNED TO EXAMINER |
| 02th Feb 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| 15th Nov 2023 | NEW APPLICATION ENTERED |